You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
熱景生物(688068.SH):擬對參股公司增資合計4000萬元
格隆匯 07-18 18:59

格隆匯7月18日丨熱景生物(688068.SH)公佈,智源生物為公司持股20%的參股公司,主要經營業務為生物創新藥和診斷試劑研發。為進一步優化公司業務佈局,拓展公司在生物創新藥領域的發展戰略,公司擬聯合戰略投資企業舜景醫藥共同出資4,000萬元對其進行增資,其中公司以自有資金3,500萬元對其進行增資,其中認購新增註冊資本42.58萬元,出資額超過所認購註冊資本的部分3,257.42萬元計入智源生物資本公積,本次增資後公司將持有智源生物23.13%股權。

智源生物是一家專注於生物技術藥物和診斷製劑研發的企業,目前開展了針對阿爾茨海默病(AD,俗稱老年性痴呆)、帕金森病(PD)、亨廷頓病(HD)、肌萎縮側索硬化症(ALS,俗稱漸凍人症)等多種神經退行性疾病原創性治療抗體藥物和診斷試劑盒的研發。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account